Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Evan Trapana

Orthopaedic Surgery Miami, FL Medical Doctor

NPI 1639610983 CMS profile 5700954

1400 Nw 12Th Ave # 2, Miami, FL 33136

Open in the dashboard

General payments

$17,661

139 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Evan Trapana of Miami, FL is reported in the CMS Open Payments database as having received $17,661 across 139 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,371 18
2024 General $4,856 60
2023 General $3,939 33
2022 General $2,495 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Evan Trapana
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Evan Trapana were reported at $6,371. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Evan Trapana Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $2,495 $598 $128–$2,731 $149
2023 $3,939 $461 $128–$2,264 $160
2024 $4,856 $497 $134–$2,475 $164
2025 $6,371 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Kuros Biosciences USA, Inc $5,868 9 payments
  2. Stryker Corporation $3,912 51 payments
  3. Globus Medical, Inc. $2,958 20 payments
  4. Spineology Inc. $872 3 payments
  5. Medical Device Business Services, Inc. $722 11 payments
  6. Seaspine Orthopedics Corporation $658 3 payments
  7. Carlsmed, Inc. $512 3 payments
  8. Arthrex, Inc. $378 8 payments
  9. DePuy Synthes Sales Inc. $309 9 payments
  10. Orthofix Medical, Inc. $292 3 payments
  11. Other $1,180 19 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $8,925 124 payments
  2. Consulting Fee $4,800 1 payment
  3. Travel and Lodging $3,937 14 payments
Products named General payments · program years 2022–2025
  1. MAGNETOS $5,735 8 payments
  2. XLIF $1,381 11 payments
  3. EVEREST SPINAL SYSTEM $1,335 8 payments
  4. SERRATO $1,058 16 payments
  5. OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM $872 3 payments
  6. Excelsius3D Imaging System $749 3 payments
  7. CONDUIT $624 8 payments
  8. ExcelsiusGPS Robotic Navigation System $540 5 payments
  9. Mariner $536 2 payments
  10. MAKO $434 3 payments
  11. Other $3,854 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

178

Median for Orthopedic Surgery: 203

Drug cost

$2,362

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 75 $1,799
Gabapentin Generic 24 $219
Methylprednisolone Generic 31 $205
Cyclobenzaprine Hcl Generic 22 $101
Tramadol Hcl Generic 14 $30
Meloxicam Generic 12 $10

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$56,367

Medicare's payments for the services billed

Medicare patients

95

Average age 72

Services billed

219

53 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 36%
Diabetes 34%
Depression 34%
Cancer 26%
Chronic kidney disease 25%
Osteoporosis 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

139 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record